Alexion Pharmaceuticals, Inc.

Since 2013, our Blanchardstown, Dublin facility has served as Alexion’s Global Supply Chain and Operations headquarters, enabling us to deliver first-class product to patients around the clock. Watch the video to hear from our Site Lead & Executive Director Maureen Larkin as she shares more about the onsite operations and vibrant team culture there: http://spr.ly/6047WUm21

We are committed to fostering a culture of continuous learning and development by offering ample opportunities for our people to thrive and progress in their careers. Hear from two of our colleagues, whose careers grew in ways they could never have imagined at Alexion.

What gets our Head of Patient Experience and Insights excited about coming to work at Alexion? The shared sense of purpose. Hear how Wendy Erler’s journey to patient advocacy began right in her own backyard–and how it has led her to become a passionate advocate for patients ever since. #LifeAtAlexion

Nick France began his career in rare disease as a pediatrician in clinical care, but he pivoted to industry to make a global impact. Watch this video to hear from him on how we’re advancing the science of genomic medicine.

New research from AstraZeneca in Nature Portfolio demonstrates the transformative potential for gene editing to transform outcomes for people living with rare genetic disorders by addressing their underlying causes.   The new gene editing tool showed enhanced precision to correct genetic mutations, while reducing off-target effects.   This advancement could help accelerate potential new treatments for a range of diseases, including rare conditions—of which 80% are believed to have a genetic cause.   Learn more here: https://lnkd.in/eWkEhvVk

Alexion’s VP CENE Area Head Dana Vigier, MD held a compelling Fireside-Chat accompanied by Oskar Ahlberg from the Swedish patient organization Riksförbundet Sällsynta diagnoser - Rare Diseases Sweden at Reuters Events Pharma in London. They explored how by better understanding and improving the reality of pharma and its engagement with external stakeholders, we enable sustainable long-term partnerships that are for the benefit of patients, healthcare providers and society. The marketing continuum, particularly in orphan disease, shows that there isn’t one customer, yet the power of decision-making lies with few and doesn’t necessarily take into consideration the needs of others. They reflected on the value of inclusion and empowerment, data driven decision making and meaningful stakeholder interactions. #REcustomerEU24 #RareDisease

#RareDisease poses its own set of unique challenges for patients—this also extends to those who care for them too. But caregivers don’t have to do it alone. Check out http://spr.ly/6011uYDOv for helpful resources

Today, on October 30, we recognise #WorldHPPDay, a day dedicated to raising awareness for those living with #Hypophosphatasia (HPP). This rare, inherited, metabolic disorder can affect people of all ages. At Alexion, we’re committed to advancing research and supporting individuals, families, and their loved ones impacted by HPP. Join us in spreading awareness and knowledge about this condition to help those affected by this rare disorder.

We truly believe Alexion is a great place to work. But don’t just take our word for it – hear perspectives from a few of our very own: http://spr.ly/6042q3AgI #LifeAtAlexion

Each year on October 26, we gather with the #Amyloidosis community in honour of #WorldAmyloidosisDay to raise awareness of amyloidosis, a group of complex rare diseases caused by abnormal proteins that misfold and clump together to form amyloids that deposit in tissues or organs. Join us in showing your support for those affected by amyloidosis and their families.